49th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Bloo...(year's Presidential Symposium will focus...)

Date:12/5/2007

year's Presidential Symposium will focus on the discovery of cancer stem cells in a variety of malignancies. The eradication of these tumor cells, which have stem cell characteristics and the capacity for self-renewal, may be necessary for long-term success in cancer treatment. During the symposium on Tuesday, December 11, from 9:30 a.m. to 12:00 noon, three pioneering investigators will discuss the properties of cancer stem cells and the potential to target them for therapy.

Hal E. Broxmeyer, PhD, Scientific Director of the Walther Oncology Center and Chair of the Department of Microbiology and Immunology at the Indiana University School of Medicine, will discuss the scientific discoveries that led to the successful use of cord and placental blood for treating malignant and non-malignant disorders, as well as ways to enhance the efficacy of cord blood transplantation in the future, at this year's E. Donnall Thomas Lecture on Monday, December 10, from 9:30 a.m. to 10:30 a.m.

Another highlight of the meeting is the annual policy forum, which is co-sponsored by ASH and the European Hematology Association. This year's session on emergency preparedness is designed to be provocative -- posing questions hematologists should consider before the next SARS, bird flu, or other public health disaster strikes -- and provide unique perspectives on how to deal with future epidemics.

Additionally, Radek C. Skoda, MD, of the University Hospital Basel in Switzerland, will give the Ham-Wasserman Lecture on Saturday, December 8, from 12:30 p.m. to 1:30 p.m. Dr. Skoda's lecture will focus on the molecular basis of myeloproliferative disorders (MPDs). Recently, the discovery of activating mutations in the Janus kinase 2 gene in the majority of MPD patients has transformed and energized the field; however, a number of questions still remain unanswered.

For the complete annual meeting program and abstracts, visit

SOURCE American Society of Hematology Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
2. Sinovac Announces Postponement of Annual General Meeting
3. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
6. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
7. ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference
8. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
9. Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference
10. Cell Genesys to Present at the Bear Stearns 20th Annual Healthcare Conference
11. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference